Core Points - Tecan Group Ltd. will propose changes to shareholders at the Annual General Meeting on April 15, 2026, including the nomination of Gitte Pugholm Aabo as a new independent member of the Board of Directors [1][5] - Lukas Braunschweiler, the current Chairman of the Board, will not stand for re-election, and Matthias Gillner is proposed as the new Chairman [5] Company Overview - Tecan is a global leader in laboratory automation, founded in Switzerland in 1980, with over 3,000 employees and operations in Europe, North America, and Asia [3] - In 2024, Tecan generated sales of CHF 934 million (USD 1,062 million; EUR 984 million) [3] - The company focuses on empowering healthcare innovation from life sciences to clinical applications [3] Board Member Qualifications - Gitte Pugholm Aabo has a strong financial background, having served as President and CEO of GN Store Nord's Hearing Business and held various roles at LEO Pharma [2][1] - Aabo is considered highly qualified to serve as a financial expert on the Board and is well-suited for membership in the Audit Committee [2]